US 11464856
Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11464856 (Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers) held by Julius-Maximilians-Universitat Wurzburg expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Julius-Maximilians-Universitat Wurzburg
- Grant date
- Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/55, A61K31/7105